[The evoluation of the strategy and tactics of treatment of Helicobacter pylori-dependent diseases].
The review analyzes the 10-year evolution of Maastricht group's views on the strategy and tactics of treatment of Helicobacter pylori-associated gastroduodenal diseases; the practical appropriateness and efficiency of Maastricht consensus 1 to 3 is discussed, and the reasons for the difficulties and failures that have taken place are reviewed. Suggestions on alternative methods and regimens of Helicobacter pylori eradication are discussed because of the growing resistance of the pathogen to the recommended antibacterial therapy. The author makes suggestions that concern overcoming bacterial resistance to treatment and increasing the efficiency of eradication therapy, as well as indications to such therapy.
Tsimmerman
Ia S
IaS
D019072:Antibiotic Prophylaxis; D024881:Drug Resistance, Bacterial; D005767:Gastrointestinal Diseases / Q000188:drug therapy* / Q000382:microbiology*; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori; D006801:Humans